Suchergebnisse - (Person:"Belizna, Cristina")

PubPharm (7)

1

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS) : from theory to reality

enthalten in: Clinical rheumatology | 2024

von Udry, S. | Latino, J. | Perez, S. | +7

2

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality

enthalten in: Clinical rheumatology | 2024

von Udry, S. | Latino, J. | Perez, S. | +7

3

Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group

enthalten in: Placenta | 2023

von Esteve-Valverde, E. | Alijotas-Reig, J. | Belizna, C. | +30

ErratumIn: Placenta. 2023 May 3;138:20. - PMID 37146536

4

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS) : A survey of 1000 consecutive cases

enthalten in: Autoimmunity reviews | 2019

von Alijotas-Reig, J. | Esteve-Valverde, E. | Ferrer-Oliveras, R. | +34

5

HIBISCUS : Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome

enthalten in: Autoimmunity reviews | 2018

von Belizna, C. | Pregnolato, F. | Abad, S. | +78

6

Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus : Are they different entities?

enthalten in: Autoimmunity reviews | 2018

von Belizna, C. | Stojanovich, L. | Cohen-Tervaert, J. | +21

7

Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome

enthalten in: Autoimmunity reviews | 2015

von Belizna, C.

1
[1]